These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 12651235

  • 1. Expressions of latent membrane protein 1, p53 and bcl-2 proteins and their significance in Hodgkin's lymphoma.
    Qi ZL, Zhao T, Zhou XH, Zhang JH, Han XQ, Zhu MG.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):225-7. PubMed ID: 12651235
    [Abstract] [Full Text] [Related]

  • 2. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
    Kanavaros P, Stefanaki K, Vlachonikolis J, Eliopoulos G, Kakolyris S, Rontogianni D, Gorgoulis V, Georgoulias V.
    Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
    [Abstract] [Full Text] [Related]

  • 3. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S.
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [Abstract] [Full Text] [Related]

  • 4. [Epstein-Barr virus infection and the expression of bcl-2 proto-oncogene in Hodgkin's disease].
    Liu C, Liao S, Gao Z.
    Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):155-7. PubMed ID: 10072857
    [Abstract] [Full Text] [Related]

  • 5. [Presence of bcl-2 and p53 proteins in patients with non-Hodgkin's lymphoma at Zadar General Hospital].
    Skunca Z, Gverić-Krecak V, Dominis M, Planinc-Peraica A, Jaksić B.
    Acta Med Croatica; 2004 Jun; 58(3):183-6. PubMed ID: 15503680
    [Abstract] [Full Text] [Related]

  • 6. Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors?
    Zafirellis K, Karameris A, Milingos N, Androulakis G.
    Anticancer Res; 2005 Jun; 25(5):3629-36. PubMed ID: 16101192
    [Abstract] [Full Text] [Related]

  • 7. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
    Sheu LF, Chen A, Lee HS, Hsu HY, Yu DS.
    Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
    [Abstract] [Full Text] [Related]

  • 8. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
    Guiretti DM, Chabay PA, Valva P, Stefanoff CG, Barros MH, De Matteo E, Renault IZ, Preciado MV, Hassan R.
    J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA, Zekri AR, Asaad N, El-Houssini S, Khalid HM, Sedky LM, Mokhtar NM.
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [Abstract] [Full Text] [Related]

  • 10. Large B-cell lymphoma with Hodgkin's features.
    García JF, Mollejo M, Fraga M, Forteza J, Muniesa JA, Pérez-Guillermo M, Pérez-Seoane C, Rivera T, Ortega P, Piris MA.
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V, Lekhyananda N, Phungrassami T, Boonyaphiphat P, Thongsuksai P.
    Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A, Rüdiger T, Marx A, Müller-Hermelink HK, Ott G.
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [Abstract] [Full Text] [Related]

  • 15. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL, Yin ZH, Liu TF, Dong BH, Zhou JG, Yao KT.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [Abstract] [Full Text] [Related]

  • 16. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
    Sup SJ, Alemañy CA, Pohlman B, Elson P, Malhi S, Thakkar S, Steinle R, Hsi ED.
    J Clin Oncol; 2005 Jun 01; 23(16):3773-9. PubMed ID: 15809450
    [Abstract] [Full Text] [Related]

  • 17. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
    Liu JR, Lin Q, Wu XY.
    Ai Zheng; 2005 Feb 01; 24(2):145-8. PubMed ID: 15694022
    [Abstract] [Full Text] [Related]

  • 18. [bcl-2 and p53 protein expressions in the malignant transformation of ovarian endometriosis].
    Qian J, Shi Y.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 01; 23(5):403-5. PubMed ID: 11810773
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
    Jung JT, Kim DH, Kwak EK, Kim JG, Park TI, Sohn SK, Do YR, Kwon KY, Song HS, Park EH, Lee KB.
    Ann Hematol; 2006 Sep 01; 85(9):575-81. PubMed ID: 16673127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.